Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhongchao (ZCMD) Short term Debt (2018 - 2024)

Zhongchao (ZCMD) reported Short term Debt of $483800.0 for Q4 2024, down 14.32% year-over-year from $564652.0 in Q1 2024, and down 14.32% on a QoQ basis from $564652.0 in Q4 2023.

Zhongchao (ZCMD) has 4 years of Short term Debt data on file, last reported at $483800.0 in Q4 2024.

  • Quarterly Short term Debt fell 14.32% year-over-year to $483800.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $483800.0 (down 14.32% YoY) and the FY2024 annual result came in at $483800.0, down 14.32% from the prior year.
  • Short term Debt fell to $483800.0 in Q4 2024 per ZCMD's latest filing, from $564652.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $762962.0 in Q4 2022 and bottomed at $483800.0 in Q4 2024.
  • The 3-year median for Short term Debt is $564652.0 (2023), against an average of $603804.7.
  • The widest annual swing landed in 2023, when Short term Debt retreated 25.99%; it then retreated 14.32% in 2024.
  • Tracing ZCMD's Short term Debt over 3 years: stood at $762962.0 in 2022, then dropped by 25.99% to $564652.0 in 2023, then fell by 14.32% to $483800.0 in 2024.
  • Per Business Quant, the three latest ZCMD Short term Debt figures stand at $483800.0 (Q4 2024), $564652.0 (Q4 2023), and $762962.0 (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Zhongchao - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 483,800.00
Dec 31, 2023 564,652.00
Dec 31, 2022 762,962.00
Dec 31, 2018 727,220.00